Tag Archives: SRPT

Top 5 Blue Chip Stocks To Buy For 2018

Shutterstock

Dont take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

Its dangerous to buy headline yields or even supposedly safe blue chips with more modest dividends without looking....More>>>

Top Biotech Stocks To Invest In 2018

Few investments have the profit potential of penny stocks, which are stocks that trade under $5 per share.

Just take a look at Marathon Patent Group Inc. (Nasdaq: MARA), which climbed an astounding 341% during the four trading days of Thanksgiving week.

Biotech penny stocks are especially attractive since successful clinical trial results for their drugs can often send their share....More>>>

Top Bank Stocks To Buy For 2019

Chairman & CEO of Comerica Inc (NYSE:CMA) Ralph W Jr Babb sold 65,300 shares of CMA on 02/02/2018 at an average price of $97.61 a share. The total sale was $6.4 million.

Comerica Inc is a financial services company. It operates in three business segments, The Business Bank, The Retail Bank, and Wealth Management. It operates in three primary geographic markets, Michigan, California and....More>>>

Sarepta Therapeutics (SRPT) Price Target Raised to $91.00 at Morgan Stanley

Sarepta Therapeutics (NASDAQ:SRPT) had its target price increased by Morgan Stanley from $87.00 to $91.00 in a report issued on Friday. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.

Other equities research analysts also recently issued research reports about the company. BidaskClub upgraded Sarepta Therapeutics from a hold rating to a buy....More>>>

Sarepta Therapeutics: Backing A Cure For Duchenne Muscular Dystrophy

Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that would facilitate the first cure for DMD and sizable growth potential.

In 2016, Sarepta Therapeutics,....More>>>

Mid-Afternoon Market Update: Crude Oil Up Over 1%; Sarepta Shares Jump After Positive Results In DMD

Toward the end of trading Wednesday, the Dow traded up 0.42 percent to 21,845.34 while the NASDAQ climbed 0.41 percent to 6,401.95. The S&P also rose, gaining 0.42 percent to 2,468.27.

Leading and Lagging Sectors

Wednesday afternoon, the energy shares surged 1.23 percent. Meanwhile, top gainers in the sector included Frontline Ltd. (NYSE: FRO), up 5 percent, and JA....More>>>

Top 10 High Tech Stocks To Invest In 2018

“Mors tua, vita mea” (literally “your death is my life) probably was the motto that gladiators, in the ancient Rome, recited before entering in the Coliseum and fighting for their life. Over and above its literal translation, this Latin expression means that what is a damage for one person is often an advantage for another. There can only be one winner in a competition; that is....More>>>

stock analyst

Click to enlarge

Quick Take

Electronics manufacturer Microphase (Pending:MPHSE) has filed an amended S-1 registration statement with notable new details.

The company experienced a severe drop in revenues and in gross margin in Q3 2016 due to a combination of factors within its control and outside its control.

Microphase has not yet provided an expected price range for....More>>>

Best Energy Stocks To Invest In Right Now

What happened

Shares of Southwestern Energy (NYSE:SWN) fell sharply on Friday, and were down more than 11% by 3:00 p.m. EST. Fueling today’s sell-off was the company’s fourth-quarter results and 2017 guidance.

So what

On the one hand, Southwestern Energy’s fourth-quarter results marked quite a turnaround for the company. That’s after it reported adjusted....More>>>

Top Low Price Stocks To Watch Right Now

EMM & QNX will be the growth drivers going forward. But the risks in BlackBerry stock continue to remain elevated.

BlackBerry(NSDQ:BBRY)stock is a very volatile stock. When the company announced its latest set of earnings on the 20th of December, the share price rose to around $8 a share, but since then has plummeted back down to the $7 level. Blackberry is unique in that it is a low....More>>>